The Global Fund has allocated a total of US$372 million (N$6.9 billion) since 2004 to support Namibia’s healthcare system in its fight against HIV, tuberculosis, and malaria.
According to recent data, allocations for specific periods include U$111,293,124 (N$2.06 billion) between 2014 and 2016 and U$37,106,905 (N$690 million) between 2017 and 2019.
The Fund also allocated U$37,402,489 (N$694 million) between 2020 and 2022, and U$32,752,913 (N$608 million) between 2023 and 2025.
The Ministry of Health and Social Services says Namibia’s proactive approach to disease control is evident, with the country nearing malaria pre-elimination and witnessing declines in tuberculosis incidence and mortality rates.
The Ministry said in honour of the 20-year partnership, the Ministry and Namibia’s Country Coordinating Mechanism will host a ceremonial signing event this week, acknowledging grants C19 RM and GC7, underscoring their joint commitment to enhancing healthcare outcomes in Namibia.
Meanwhile, from 2014 through 2016, Namibia was allocated a substantial sum of U$111,293,124 (N$2.06 billion). Of this amount, U$87.68 million (N$1.63 billion) was earmarked for HIV initiatives, U$18.12 million (N$337 million) for tuberculosis, and U$5.49 million (N$102 million) for malaria control efforts.
Continuing its commitment, the Global Fund allocated U$37,106,905 (N$690 million) to Namibia between 2017 and 2019.
This allocation saw, “U$29.41 million (N$547 million) directed towards HIV programmes, U$5.88 million (N$109 million) for tuberculosis, and U$1.82 million (N$34 million) for malaria interventions.”
In the subsequent period of 2020-2022, Namibia received a similar allocation totalling U$37,402,489 (N$694 million).
Of this amount, U$28.30 million (N$525 million) was designated for HIV initiatives, U$6.01 million (N$112 million) for tuberculosis, and U$3.09 million (N$57 million) for malaria control.
Similarly, from 2023-2025 Namibia is slated to receive U$32,752,913 (N$608 million) from the Global Fund.
This allocation will see $23.91 million (N$444 million) allocated for HIV programs, U$5.74 million (N$107 million) for tuberculosis, and U$3.09 million (N$57 million) for malaria initiatives.
The Global Fund has one core grant currently active in Namibia: a joint HIV, tuberculosis (TB) and malaria grant of up to US$39.5 million (N$734 million) for 2021-2023.
“Our investment supports the country’s ongoing epidemic response, which has made progress against all three diseases,” said the Fund.
